Reports > Life Sciences > Minimally Invasive Glaucoma Surgery Migs Devices Market Report
Minimally Invasive Glaucoma Surgery Migs Devices Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Minimally Invasive Glaucoma Surgery (MIGS) Devices market from 2023 to 2033. It covers key trends, market size, regional analyses, and insights regarding technological advancements and product performance.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.80 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $5.78 Billion |
| Top Companies | Allergan, Glaukos Corporation, Aquesys, iScience Interventional |
| Last Modified Date | 15 Nov 2024 |
Minimally Invasive Glaucoma Surgery Migs Devices Market Report (2023 - 2033)
Minimally Invasive Glaucoma Surgery Migs Devices Market Overview
What is the Market Size & CAGR of Minimally Invasive Glaucoma Surgery Migs Devices market in {Year}?
Minimally Invasive Glaucoma Surgery Migs Devices Industry Analysis
Minimally Invasive Glaucoma Surgery Migs Devices Market Segmentation and Scope
Request a custom research report for industry.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis Report by Region
Europe Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
In Europe, the market size is anticipated to rise from $0.71 billion in 2023 to approximately $1.47 billion by 2033. The combination of an aging population and increasing prevalence of glaucoma is gearing the demand for MIGS devices.Asia Pacific Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
In the Asia Pacific region, the MIGS devices market is projected to grow from $0.56 billion in 2023 to approximately $1.16 billion by 2033. The increasing demand for advanced glaucoma treatment options and rising investments in healthcare infrastructure are crucial growth drivers.North America Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
North America dominates the MIGS market with a projected increase from $0.92 billion in 2023 to about $1.91 billion by 2033. Factors such as high healthcare expenditure, advanced healthcare technologies, and a robust distribution channel network facilitate this growth.South America Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
The South American market for MIGS devices is expected to expand from $0.26 billion in 2023 to $0.54 billion by 2033. The growth in this region is driven by increasing awareness about glaucoma and rising incidences.Middle East & Africa Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
The Middle East and Africa MMC devices market is set to grow from $0.34 billion in 2023 to around $0.70 billion by 2033. Improvements in healthcare infrastructure and rising awareness about eye care are expected to contribute substantially.Request a custom research report for industry.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Device Type
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Device Type Market Analysis (2023 - 2033)
The MIGS devices market is primarily driven by the stents segment, which is estimated to maintain a significant market share. Stents are projected to grow from $1.77 billion in 2023 to $3.66 billion by 2033, catering to a large percentage of patients diagnosed with glaucoma. Shunts and surgical instruments are secondary devices but play an essential role in overall therapeutic strategies, with corresponding growth rates expected in line with stents.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Application
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Application Market Analysis (2023 - 2033)
The application segment is dominated by Open Angle Glaucoma, which is forecasted to capture the largest market share, growing from $1.77 billion in 2023 to $3.66 billion by 2033. Angle Closure Glaucoma and Secondary Glaucoma segments follow, reflecting significant growth trends due to awareness and diagnosis improvements.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By End User
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End User Market Analysis (2023 - 2033)
The end-user analysis shows hospitals leading preference, expected to maintain a share of approx. 63.31% throughout the forecast period, as a primary platform for MIGS surgeries. Clinics and ambulatory surgery centers are also growing, responding to increased patient outflow and demand for outpatient procedures.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Region
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Distribution Channel Market Analysis (2023 - 2033)
The distribution channel analysis indicates that direct sales remain predominant, contributing to approximately 63.31% of the market in 2023 and continuing until 2033. Distributors and online retail channels are increasingly adopted, enhancing market reach.
Minimally Invasive Glaucoma Surgery Migs Devices Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Minimally Invasive Glaucoma Surgery Migs Devices Industry
Allergan:
A prominent player in eye care, Allergan is known for its advanced MIGS technologies, significantly enhancing glaucoma treatment options.Glaukos Corporation:
A leader in the development of innovative MIGS procedures, Glaukos Corporation pioneered multiple stent solutions that have transformed the surgical approach to glaucoma treatment.Aquesys:
Aquesys specializes in developing minimally invasive stenting procedures and devices designed for glaucoma treatment, extensively focusing on patient recovery and procedural efficiency.iScience Interventional:
iScience is recognized for its advanced product portfolio, particularly its innovative techniques that help minimize complications while enhancing treatment outcomes.We're grateful to work with incredible clients.
